Decentralized Clinical Trials Market: By Study Design (Interventional, Observational, and Expanded Access), By Component (Mobile Healthcare, Telemedicine, Wearable Devices, Web-Based Technology, and Others), By Application (Peripheral Vascular Disease, Oncology, Neurology, Urology, and Others), and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Decentralized Clinical Trials Market size was valued at USD 1,675.5 million in 2022 and is expected to grow USD 4,508.2 million in 2029, at a CAGR of 9.8% from 2023 to 2029. A study executed through telemedicine, mobile, and local healthcare providers using a process of technology differing from the traditional clinical method approach is known as a decentralized clinical trial. The market is segmented on study design and includes interventional, observational, and expanded access data, observational data are mainly collected from healthcare providers and telemedicine providers. The DCT market is a fast-growing market that provides incorporation with digital clinical trials. The DCT models provide benefits to patients and sponsors as compared to traditional clinical trials. The demand for accurate and high-quality data enhanced patient convenience and experience, lowered the burden of travel, and decreased time-consuming in-patient visits are the major factors driving the market of decentralized clinical trials market. Regulatory agencies are following various factors for decentralized clinical trials to approach but there is no international standard, which increases the demand for sponsorship for decentralized clinical trials, Although, the reimbursement policies by the government are the key opportunities in the overall Decentralized clinical trials market. Controlling costs, approval from a government authority, recruitment of participants, retaining participants, and completing of trial on time are the major challenges in the decentralized clinical trial. The adoption of artificial intelligence tools for clinical trials is a major recent trend in the market.

Decentralized Clinical Trials Market Key Developments:
  • In November 2022, Clalit Health Services collaborated with IQVIA to work with the clinical trial industry.
  • In October 2022, PPD Inc., a pharmaceutical company, introduced a new decentralized clinical trial network to facilitate participation in the decentralized clinical market. 

Decentralized Clinical Trials Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

9.8%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Decentralized Clinical Trials Market Dynamics

The increasing prevalence of mobile healthcare and the increase in sponsorship in a clinical trials in the world is the major market driver in the Decentralized Clinical Trials Market during the forecast period. Enhanced patient convenience towards health care and skilled professional for health consultants are major demand in the market, also in pharmaceutical to increase research and development activity, with this increasing number of clinical trials and high cost for drug manufacturing also in R&D facility, are dependent on data and information from outsourced firms, increased in the demand for sponsorship for decentralized clinical trials. Hence, this will drive global market growth at a significant rate.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Decentralized Clinical Trials Market Segmentation

By Study Design
  • Interventional
  • Observational 
  • Expand Access 
By Application
  • Peripheral Vascular Disease
  • Oncology
  • Neurology
  • Urology
  • Others
By End User
  • Hospitals 
  • Ambulatory Surgical Centers 
  • Diagnostic Centers
  • Others
By Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA
LOCATION

Geography

Frequently Asked Questions

The Decentralized clinical trials market size was valued at USD 1,675.5 million in 2022 and expected to reach USD 4,508 million in 2028, growing at an 9.8% CAGR from 2023 to 2029

A study executed through telemedicine, mobile, and local healthcare providers using the process of technology differs from the traditional clinical method approach is known as a decentralized clinical trial.

The leading players in the Decentralized Clinical Trials Market are; Medidata, IQVIA, LabCorp, PRA Health Sciences, Parexel, ICON, Oracle, CRF Health, Clinical Ink, Medable, Science 37, LEO Innovation Lab, Covance, Thermo Fisher, Huma, Signant Health

Historic years considered for the market study are 2018 through 2022, 2022 is considered as the base year for market estimation, and Seven years forecast is presented from 2023 – 2029.

1.Executive Summary
2.Global Decentralized Clinical Trials Market Introduction 
2.1.Global Decentralized Clinical Trials Market  - Taxonomy
2.2.Global Decentralized Clinical Trials Market  - Definitions
2.2.1.Study Design
2.2.2.Application
2.2.3.End User
2.2.4.Region
3.Global Decentralized Clinical Trials Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Decentralized Clinical Trials Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Decentralized Clinical Trials Market  By Study Design, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Interventional
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Observational 
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Expand Access 
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Decentralized Clinical Trials Market  By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Peripheral Vascular Disease
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Oncology
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Neurology
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Urology
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global Decentralized Clinical Trials Market  By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Hospitals 
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Ambulatory Surgical Centers 
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Diagnostic Centers
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Others
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Decentralized Clinical Trials Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Decentralized Clinical Trials Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Study Design Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Interventional
9.1.2.Observational 
9.1.3.Expand Access 
9.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Peripheral Vascular Disease
9.2.2.Oncology
9.2.3.Neurology
9.2.4.Urology
9.2.5.Others
9.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals 
9.3.2.Ambulatory Surgical Centers 
9.3.3.Diagnostic Centers
9.3.4.Others
9.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Decentralized Clinical Trials Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Study Design Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Interventional
10.1.2.Observational 
10.1.3.Expand Access 
10.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Peripheral Vascular Disease
10.2.2.Oncology
10.2.3.Neurology
10.2.4.Urology
10.2.5.Others
10.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals 
10.3.2.Ambulatory Surgical Centers 
10.3.3.Diagnostic Centers
10.3.4.Others
10.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11.Asia Pacific (APAC) Decentralized Clinical Trials Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Study Design Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Interventional
11.1.2.Observational 
11.1.3.Expand Access 
11.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Peripheral Vascular Disease
11.2.2.Oncology
11.2.3.Neurology
11.2.4.Urology
11.2.5.Others
11.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals 
11.3.2.Ambulatory Surgical Centers 
11.3.3.Diagnostic Centers
11.3.4.Others
11.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Decentralized Clinical Trials Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Study Design Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Interventional
12.1.2.Observational 
12.1.3.Expand Access 
12.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Peripheral Vascular Disease
12.2.2.Oncology
12.2.3.Neurology
12.2.4.Urology
12.2.5.Others
12.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals 
12.3.2.Ambulatory Surgical Centers 
12.3.3.Diagnostic Centers
12.3.4.Others
12.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Decentralized Clinical Trials Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Study Design Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Interventional
13.1.2.Observational 
13.1.3.Expand Access 
13.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Peripheral Vascular Disease
13.2.2.Oncology
13.2.3.Neurology
13.2.4.Urology
13.2.5.Others
13.3.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals 
13.3.2.Ambulatory Surgical Centers 
13.3.3.Diagnostic Centers
13.3.4.Others
13.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Medidata
14.2.2.IQVIA
14.2.3.LabCorp
14.2.4.PRA Health Sciences
14.2.5.Parexel
14.2.6.ICON
14.2.7.Oracle
14.2.8.CRF Health
14.2.9.Clinical Ink
14.2.10.Medable
14.2.11.Science 37 
14.2.12.LEO Innovation Lab
14.2.13.Covance
14.2.14.Thermo Fisher
14.2.15.Huma
14.2.16.Signant Health
15. Research Methodology 
16. Appendix and Abbreviations 
  • Medidata
  • IQVIA
  • LabCorp
  • PRA Health Sciences
  • Parexel
  • ICON
  • Oracle
  • CRF Health
  • Clinical Ink
  • Medable
  • Science 37
  • LEO Innovation Lab
  • Covance
  • Thermo Fisher
  • Huma
  • Signant Health

Adjacent Markets